Literature DB >> 19230046

Epidemiology of hepatitis B virus infection in Albania.

Bashkim Resuli1, Skerdi Prifti, Bledar Kraja, Tatjana Nurka, Mimoza Basho, Edita Sadiku.   

Abstract

AIM: To assess the prevalence and socio-demographic distribution of hepatitis B virus (HBV) infection in Albania.
METHODS: Blood samples from 410 unselected schoolboys, 666 students, 500 military personnel, 1286 casual blood donors, 378 voluntary blood donors and 640 pregnant women (total 3880 non-vaccinated residents of rural and metropolitan areas from all over Albania; 2354 (60.7%) male and 1526 (39.3%) female; mean age of 26.3 years) were tested during 2004-2006 for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B virus (anti-HBs) by ELISA.
RESULTS: The HBsAg and anti-HBs prevalence were 9.5% and 28.7%, respectively. The highest HBsAg prevalence was evident in the younger age group, such as in schoolchildren (11.8%) and the military (10.6%). Consequently, the anti-HBs prevalence increased with age, from 21.2% in schoolchildren (mean age: 15.7 years), to 36.3% in pregnant women (mean age: 26.3 years) and 29.7% in voluntary blood donors (mean age: 40.1 years). There were no significant differences between males and females.
CONCLUSION: Despite the estimated two-fold reduction of HBsAg prevalence in the general population from about 18%-19% to 9.5%, Albania remains a highly endemic country (i.e. over 8% of HBsAg prevalence rate).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230046      PMCID: PMC2653385          DOI: 10.3748/wjg.15.849

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Toward the global elimination of hepatitis B virus transmission.

Authors:  S T Goldstein; A E Fiore
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

2.  Rationale for the infant and adolescent vaccination programmes in Italy.

Authors:  G Da Villa
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

3.  Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme.

Authors:  F Z Al-Faleh; M Al-Jeffri; S Ramia; R Al-Rashed; M Arif; M Rezeig; I Al-Toraif; M Bakhsh; A Mishkkhas; O Makki; H Al-Freihi; S Mirdad; A AlJuma; T Yasin; A Al-Swailem; A Ayoola
Journal:  J Infect       Date:  1999-05       Impact factor: 6.072

4.  Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection.

Authors:  L A Kondili; D Ulqinaku; M Hajdini; M Basho; P Chionne; E Madonna; G Taliani; A Candido; P Dentico; S Bino; M Rapicetta
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

5.  Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.

Authors:  R Harpaz; B J McMahon; H S Margolis; C N Shapiro; D Havron; G Carpenter; L R Bulkow; R B Wainwright
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Impact of hepatitis B immunisation as part of the EPI.

Authors:  Y Poovorawan; A Theamboonlers; T Vimolket; S Sinlaparatsamee; K Chaiear; T Siraprapasiri; S Khwanjaipanich; S Owatanapanich; P Hirsch; S Chunsuttiwat
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

7.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

8.  Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

Authors:  Yu-Cheng Lin; Mei-Hwei Chang; Yen-Hsuan Ni; Hong-Yuan Hsu; Ding-Shinn Chen
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

Review 9.  Status of hepatitis B immunization programmes in 1998.

Authors:  M A Kane
Journal:  Vaccine       Date:  1998-11       Impact factor: 3.641

10.  Adherence to the screening program for HBV infection in pregnant women delivering in Greece.

Authors:  Vassiliki Papaevangelou; Christos Hadjichristodoulou; Dimitrios Cassimos; Maria Theodoridou
Journal:  BMC Infect Dis       Date:  2006-05-09       Impact factor: 3.090

View more
  7 in total

1.  Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.

Authors:  Dušan Vučetić; Gorica Kecman; Vesna Ilić; Bela Balint
Journal:  Blood Transfus       Date:  2015-05-22       Impact factor: 3.443

Review 2.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

4.  Hepatitis B markers and vaccination-induced protection rate among Albanian pregnant women in Greece.

Authors:  Ioannis-S Elefsiniotis; Elena Vezali; Hero Brokalaki; Konstantinos Tsoumakas
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

Review 5.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

6.  Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients.

Authors:  Bledar Kraja; Iris Mone; Ilir Akshija; Adea Koçollari; Skerdi Prifti; Genc Burazeri
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

7.  Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

Authors:  A von Laer; M Diercke; M An der Heiden; D Altmann; R Zimmermann; S Dudareva
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.